Stocktoria
DYADIC INTERNATIONAL INC DYAI
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2004-11-05
DYADIC INTERNATIONAL INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -232.8% | -168.8% | -283.9% | -346.9% | -612.7% |
| Net margin | -238.3% | -166.2% | -234.4% | -332.2% | -543.7% |
| Return on assets | -74.0% | -58.5% | -82.7% | -71.0% | -61.4% |
| Return on equity | -597.6% | -235.2% | -115.6% | -87.8% | -71.1% |
| Current ratio | 2.68 | 4.01 | 3.58 | 5.48 | 8.22 |
| Revenue growth | -11.6% | 20.6% | -1.1% | 21.9% | 50.1% |
Source: SEC EDGAR filings · CIK 0001213809 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.